Skip to main content
SAPPORO CLINICAL LABORATORY INC. logo

SAPPORO CLINICAL LABORATORY INC. — Investor Relations & Filings

Ticker · 9776 ISIN · JP3321100004 T Human health and social work activities
Open in API
Filings indexed 60 across all filing types
Latest filing 2024-02-13 Interim / Quarterly Rep…
Country JP Japan
Listing T 9776

About SAPPORO CLINICAL LABORATORY INC.

https://www.saturin.co.jp/

SAPPORO CLINICAL LABORATORY INC. is a comprehensive healthcare services company primarily engaged in clinical laboratory testing and the operation of dispensing pharmacies. The company provides a wide array of testing services to medical institutions, including clinical and pathological examinations, biochemical and hematological analyses, microbiological assessments, and genetic testing. Additional services cover food hygiene and environmental inspections, radiation management, and electrocardiographic examinations. In addition to its laboratory operations, the company runs a network of dispensing pharmacies. It also offers support services for clinic openings, focusing on supporting regional healthcare with an emphasis on quality and safety management.

Recent filings

Filing Released Lang Actions
四半期報告書－第60期第3四半期(2023/10/01－2023/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the third quarter of the fiscal year 2024, filed by Sapporo Clinical Laboratory Inc. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the period from April 1, 2023, to December 31, 2023. It also includes management analysis and notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-02-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-4-8 of the Financial Instruments and Exchange Act, which accompanies a Quarterly Report (第２四半期報告書). Since the document is a formal regulatory filing confirming the accuracy of the quarterly report and is submitted to the Hokkaido Local Finance Bureau, it falls under the category of Regulatory Filings (RNS) as it is a specific regulatory compliance document rather than the quarterly report itself or a simple announcement.
2023-11-13 Japanese
四半期報告書－第60期第2四半期(2023/07/01－2023/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the second quarter (Q2) of the 60th fiscal period, covering the period from April 1, 2023, to September 30, 2023. It includes detailed financial statements (balance sheets, etc.), management analysis, and audit review information. This fits the definition of an Interim/Quarterly Report (IR). H1 2024
2023-11-13 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, specifically accompanying a Quarterly Report (第１四半期報告書). While it references the quarterly report, the document itself is a formal regulatory filing confirming the accuracy of the report's contents. Since it is a specific regulatory filing required by law and does not fit into the 'Interim/Quarterly Report' category (which would be the report itself) or 'Report Publication Announcement' (as it is a formal legal confirmation), it is best classified as a Regulatory Filing.
2023-08-09 Japanese
四半期報告書－第60期第1四半期(2023/04/01－2023/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Hokkaido Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the first quarter of the fiscal year ending 2024. It provides substantive financial data and management analysis, fitting the definition of an Interim/Quarterly Report (IR). Q1 2024
2023-08-09 Japanese
内部統制報告書－第59期(2022/04/01－2023/03/31)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act of Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of regulatory filing, which is a standalone report on internal control systems rather than a full annual report or a simple announcement, falls under the 'Regulatory Filings' category as it is a specific statutory requirement in Japan that does not fit into the other specialized categories like 10-K or IR.
2023-06-29 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.